Initial assessment for patients with HIV: Difference between revisions
From IDWiki
m (→: fixed link) |
(→: added OCC guideline testing) |
||
| Line 8: | Line 8: | ||
* HIV-specific |
* HIV-specific |
||
** CD4 count |
** CD4/CD8 count |
||
** HIV-RNA viral load |
** HIV-RNA viral load |
||
** HIV genotype |
|||
** HLA B5701 genotyping (for abacavir) |
** HLA *B5701 genotyping (for abacavir) |
||
** Genetic resistance assays |
** Genetic resistance assays (± tropism testing for CCR5 inhibitors) |
||
** G6PD deficiency |
** G6PD deficiency |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
* Routine |
* Routine |
||
** CBC, lytes, creatinine |
** CBC, lytes, creatinine |
||
** Fasting lipids |
** Fasting lipids, Hb A1c |
||
** Urinalysis (glucose and protein) |
** Urinalysis (glucose and protein) |
||
** Consider bone mineral density testing and vitamin D levels |
|||
| ⚫ | |||
** TB skin test |
|||
** Consider chest x-ray |
|||
** HAV-IgG, HBV-sAg/sAb/cAb, and HCV-Ab |
|||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
* For women and trans men |
|||
** Pap smear |
|||
** Rubella serology |
|||
** Trichomonas testing |
|||
== Initial regimens == |
== Initial regimens == |
||
Revision as of 00:53, 23 September 2019
History
- Date and context of diagnosis
- History of Opportunistic infections in HIV
- Sexual history
Investigations
- HIV-specific
- CD4/CD8 count
- HIV-RNA viral load
- HIV genotype
- HLA *B5701 genotyping (for abacavir)
- Genetic resistance assays (± tropism testing for CCR5 inhibitors)
- G6PD deficiency
- Routine
- CBC, lytes, creatinine
- Fasting lipids, Hb A1c
- Urinalysis (glucose and protein)
- Consider bone mineral density testing and vitamin D levels
- STIs and coinfections
- TB skin test
- Consider chest x-ray
- HAV-IgG, HBV-sAg/sAb/cAb, and HCV-Ab
- Syphilis
- Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
- Toxoplasma, varicella, CMV, and measles serologies
- For women and trans men
- Pap smear
- Rubella serology
- Trichomonas testing
Initial regimens
- All are integrase inhibitor with two nucleoside analogues
- Consider one of the [HIV single-tablet regimens](Single-tablet regimens.md)
- Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
- Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
- Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
- Complera: emtricitabine/rilpivirine/tenofovir disoproxil
